About Sagility India Limited bond.

This comprehensive profile covers key factual information about Sagility India Limited. SIL is a technology enabled, pure play BPM service provider in the healthcare domain serving the respective US market. The company was incorporated in 2021, while its business began effectively from January 6, 2022, when it was acquired from HGS at a purchase consideration of $1.2 billion by EQT (European investment firm). The company offers diverse services across the healthcare value chain for payers and providers which include clinical, case management, member engagement, payment integrity, claims cost containment, revenue cycle management and analytics, among others. Its customer base includes reputed insurance players, hospitals and laboratories/durable medical equipment manufacturers of the US market. It delivers these services through five global service delivery locations in India, the Philippines, the U.S., Jamaica and Colombia. SIL has also filed the draft red herring prospectus (DRHP) in June 2024 for its planned initial public offering (IPO) to raise funds through a secondary issue. The funds are likely to be utilised by its sponsor to reduce the debt at its level. ICRA has also taken note of the ongoing litigation in one of SIL’s subsidiaries. While any losses arising out of the litigation are expected to be indemnified by the erstwhile promoter (HGS), adverse developments in this matter shall remain a monitorable. EPS in Mar-2024 was 0.53. Current ratio in Mar-2024 was 1.18. Debt/Equity in Mar-2024 was 0.52. Debt/EBITDA in Mar-2024 was 2.98. Interest coverage ratio in Mar-2024 was 2.31. Operating Cashflow to total debt in Mar-2024 was 0.29. Total revenue for Mar-2025(E) was ₹7,154.76. Net income for Mar-2025(E) stood at ₹355.19. Total assets as of Mar-2024 were ₹10,528.83. Operating cash flow for Mar-2024 was ₹973.26. The company’s borrowing relationships include ICICI Bank Limited (₹N/A Cr), HDFC Bank Limited (₹N/A Cr), Axis Bank Limited (₹N/A Cr), Standard Chartered Bank (₹N/A Cr), HSBC Limited (₹N/A Cr), (₹N/A Cr). Peers and comparison entities consist of Sagility India Limited, Indian Railway Finance Corp Limited, Power Finance Corporation Limited, REC Limited. As of Dec 2024, promoters hold N/A% while others hold N/A% of equity. Key strengths include: Liquidity position: Adequate; Established track record of serving the US healthcare sector ; Reputed customer base; Global delivery footprint helps drive steady revenue growth and healthy operating profitability. Key risks include: Client and sectoral concentration risks; Exposure to high attrition inherent in BPM industry. Leadership team details include Ramesh Gopalan (Managing Director and Group CEO), Sarvabhouman Doraiswamy Srinivasan (Group Chief Financial Officer), Satishkumar Sakharayapattana Seetharamaiah (Company Secretary and Compliance Officer), Hari Gopalakrishnan (Non-Executive Non-Independent Director), Martin I. Cole (Non-Executive Non-Independent Director), William Winkenwerder (Independent Director), Anil Chanana (Independent Director), Ginger Dusek (Independent Director), Dr. Shalini Sarin (Independent Director), Venkat Krishnaswamy (Independent Director), Mohit Saxena (Head of Operations – India and Philippines), Anand Biradar (Head of Operations – Americas), Madan Moudgal (Head of Technology Solutions). This detailed corporate overview is structured to provide a thorough understanding of all available data points, enhance search visibility, and support investor analysis.